Skip to main content
. 2019 Feb 8;3(1):e167. doi: 10.1097/HS9.0000000000000167

Figure 3.

Figure 3

Outcome according to pre-HSCT MN1/ABL1 copy numbers for the whole cohort (n = 124). According to high versus low, 0.30 cut, (A) cumulative incidence of relapse and (B) overall survival; and according to the topmost versus higher versus low, 0.87 and 0.30 cut, (C) cumulative incidence of relapse and (D) overall survival. ABL1 = Abelson murine leukemia viral oncogene homolog 1 gene, HSCT = hematopoietic stem cell transplantation, MN1 = meningioma-1 gene.